- Home/In The News/Blog/2013/November
19
November2013
category:
503b CompoundingBill on Drug Compounding Clears Congress a Year After a Meningitis Outbreak
A bill that would give the Food and Drug Administration more power to police compounding pharmacies passed its final hurdle in Congress on Monday, in what experts said was an important step to a safer drug supply in the United States. The bill, which cleared the Senate without opposition, stops short of giving the F.D.A. […]
read more19
November2013
category:
503b CompoundingBill boosting FDA authority over compounding pharmacies heads to Obama
The U.S. Senate voted Monday to strengthen the Food and Drug Administration’s authority over compounding pharmacies that produce large volumes of mixed drugs. The president is expected to sign the legislation, which will reach his desk about a year after drugs distributed by one such compounder led to a deadly multistate meningitis outbreak. Lauded by […]
read more19
November2013
category:
503b CompoundingDrug Mixers Opened To FDA
WASHINGTON—A bill to regulate so-called compounding pharmacies is headed to the president for his expected signature, a little more than a year after tainted steroid injections from one such enterprise caused more than 750 cases of spinal meningitis. Compounding pharmacies mix drugs for patients, but some mix drugs for thousands of patients and perform […]
read more